Athersys faces setback as stroke therapy fails trial
FierceBiotech - 10-Oct-2023Enrollment paused, but $1.5 million secured from new partnership
Join the club for FREE to access the whole archive and other member benefits.
Senior Editor at Fierce Biotech
Annalee Armstrong is a senior editor at Fierce Biotech. She joined the team in April 2021, after serving as an associate editor for S&P Global Market Intelligence’s healthcare news team. Before that, she reported on climate and energy policy as the EPA reporter on Capitol Hill in Washington, D.C. Annalee began her journalism career at daily newspapers across Western Canada, covering everything from sled dogs to other local stories.
Visit website: https://www.fiercebiotech.com/person/annalee-armstrong-0
See also
Web resource providing the latest biotech news, articles, and resources related to biotech company news
Details last updated 18-Nov-2024
Enrollment paused, but $1.5 million secured from new partnership